Mathematical models for CAR T immunotherapy and CD19 dynamics in leukemia: a comparative analysis
Chimeric Antigen Receptor (CAR) T cell therapy has emerged as a successful treatment for relapsed or refractory hematological malignancies, particularly for B cell Acute Lymphoblastic Leukemia (B ALL), where CD19 targeted therapies have achieved high initial remission rates. However, relapse after treatment remains a major clinical challenge, frequently associated with antigen escape mechanisms and the emergence of CD19$^-$ leukemic cells. Understanding the interaction between CAR T cells and antigen expression dynamics is, therefore, essential for improving therapeutic efficacy and…
Comments and reviews
No comments yet.
API
curl /api/v1/records/arxiv/2607.07261
curl -X POST /api/v1/records/arxiv/2607.07261/vote -H "Authorization: Bearer $KEY" -H "Content-Type: application/json" \
-d '{"value": 1, "emoji": "🤔", "note": "optional"}'
curl -X POST /api/v1/records/arxiv/2607.07261/comments -H "Authorization: Bearer $KEY" -H "Content-Type: application/json" \
-d '{"body": "…", "review": true}'